Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: B120217A, Exp 05/15 - US Distribution
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Gilead Sciences, Inc.
- Reason for Recall:
- Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Product Codes/Lot Numbers:
Lot #: B120217A, Exp 05/15 - US Distribution
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-324-2013
Related Recalls
Presence of Particulate Matter: Presence of glass particle.
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Defective Container; leaking around the cap